EP1368012A2 - Utilisation d'un ou plusieurs shogaol(s) en tant qu'aphrodisiaque - Google Patents

Utilisation d'un ou plusieurs shogaol(s) en tant qu'aphrodisiaque

Info

Publication number
EP1368012A2
EP1368012A2 EP02713011A EP02713011A EP1368012A2 EP 1368012 A2 EP1368012 A2 EP 1368012A2 EP 02713011 A EP02713011 A EP 02713011A EP 02713011 A EP02713011 A EP 02713011A EP 1368012 A2 EP1368012 A2 EP 1368012A2
Authority
EP
European Patent Office
Prior art keywords
shogaol
rhizomes
advantageously
extract
plant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02713011A
Other languages
German (de)
English (en)
French (fr)
Inventor
Daniel Jean
Léon Cariel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LMD SAS
Original Assignee
LMD SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LMD SAS filed Critical LMD SAS
Publication of EP1368012A2 publication Critical patent/EP1368012A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9062Alpinia, e.g. red ginger or galangal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence

Definitions

  • TITLE "USE OF ONE OR MORE SHOGAOL (S) AS AN APHRODISIAC".
  • the present invention relates to aphrodisiacs. It relates in particular to the use of one or more shogaol (s) as an aphrodisiac. Since the dawn of time, many substances have been used for the purpose of increasing sexual desire (libido). Some of them have been very successful and have been passed down over the centuries. However, none of these substances has survived the scrutiny of scientists. As a result, the search for a real aphrodisiac continues. The Applicant has surprisingly discovered that the shogaol (s) have had an aphrodisiac action on both men and women.
  • Shogaols have already been described as having deodorant and / or antiseptic activity (FR 2758086).
  • Some shogaols are also known chemical constituents of plants of the Aîpinia genus, such as Alpinia galanga or Alpinia officinarum or Zingiber, such as Zingiber officinalis, Zingiber cassumunar or Zingiber zerumbet, obtained by extraction from their rhizome.
  • the ginger belonging to the family of Zingiber officinalis is a spice well like and used in many culinary preparations and has the reputation of being an aphrodisiac.
  • the quantity of chemical constituents present in its rhizome (geraniol, geranyl acetate, linalool, lemonyl acetate, ⁇ -terpineol, borneol, bornyl acetate, neral, genital, ⁇ -bisabolene, (-) - zingiberene, ( +) - r-curcumene, ⁇ -sesquiphellandrène, gingerols etc.), it is difficult to know to which or to which of these this aphrodisiac activity is due.
  • the applicant has therefore surprisingly discovered that the shogaol (s), compound (s) of the family of arylalkanones, had (a) an aphrodisiac action on the man and / or the woman.
  • the present invention therefore relates to the use of one or more shogaol (s) as an aphrodisiac.
  • aphrodisiac in the sense of the present invention, the stimulation or the awakening of the libido, i.e. of the sexual desire.
  • the present invention relates to the use of one or more shogaol (s) as an erectogen or to stimulate or stimulate the libido in humans.
  • s shogaol
  • the shogaol (s) correspond (s) to the general formula
  • n is equal to 1, 2, 4, 6 or 8 and which are respectively named [3] - shogaol, [4] -shogaol, [6] -shogaol, [8] -shogaol and [10] -shogaol.
  • the shogaol (s) are in the form of a crude extract of a plant of the family Zingiberaceae, advantageously by a process which comprises the following step: a) preparation of crude extract from rhizomes, fresh or dried, of said plant, by maceration of a ground material of these rhizomes at a temperature between 10 and 35 ° C, followed by one or more reflux extractions of this ground material, or by subjecting a ground material of said rhizomes to percolation at a temperature between 10 and 35 ° C, each of these operations (maceration, reflux extraction and percolation) being carried out using an organic solvent or a mixture of appropriate organic solvents.
  • the maceration of the ground rhizomes, prior to its extraction, has the main effect of improving the contacting of the plant tissues and the solvent during the extraction. Its duration can be between a dozen hours and a week depending on the state of freshness of the rhizomes used.
  • organic solvents are used which are miscible with water and have a relatively low boiling point so that they can be easily removed later by simple evaporation.
  • organic solvents such as ethanol, methanol, acetone or their mixtures with water.
  • shogaols are soluble in many organic solvents, it is also possible to use other organic solvents such as ethyl acetate, ethyl ether, chloroform or methylene chloride.
  • the shogaol (s) are in the form of a purified extract of a plant of the zingiberaceae family, advantageously obtained by a process which comprises, in addition to step a) described below above, the following additional steps: b) purification of the crude extract obtained in step a) by subjecting said extract, after elimination of the solvent or solvents which it contains and its recovery in water, to one or more several extractions against the current using an organic solvent or a mixture of organic solvents immiscible with water and, if desired, c) chromatographic separation of the shogaols.
  • the water-immiscible organic solvent (s) useful for carrying out the counter-current extractions of the crude extract with a view to its purification are, in particular, chosen from ethyl acetate, ethyl ether, chloroform , methylene chloride and mixtures thereof.
  • the plant of the zingiberaceae family is chosen from the species Alpinia galanga, Alpinia officinarum, Zingiber officinalis, Zingiber cassumunar and Zingiber zerumbet, even more advantageously, it is V Alpinia galanga.
  • [3] -shogaol, [6] -shogaol and [8] -shogaol can be extracted from plants of the genus Alpinia such as : lpinia galanga or Alpinia officinarum, while [4] -shogaol and [10] -shogaol can be extracted from plants of the genus Zingiber such as Zingiber officinalis, Zingiber cassumunar or Zingiber zerumbet, in particular using the method as described above.
  • the raw extract of Alpinia galanga contains a quantity of
  • [3] -shogaol comprised by weight between approximately 1 to 5% of the dry weight of said extract.
  • this extract is obtained from rhizomes, fresh or dry, of said plant.
  • the purified extract pin'Alpinia galanga contains an amount of [3] -shogaol at least equal by weight to 75% of the dry weight of said extract.
  • the present invention also relates to the use of one or more shogaol (s) for the preparation of an aphrodisiac composition.
  • the aphrodisiac composition is formulated for oral administration, for example, in the form of powders, solutions or oral suspensions, syrups, tablets or capsules.
  • the present invention also relates to a method for arousing or stimulating libido in human beings, characterized in that it comprises the administration to a human being of an effective amount of one or more shogaol (s) such (s) as defined above.
  • s shogaol
  • Example 1 Preparation of a crude extract of rhizomes of Alpinia galanga
  • a kilo of fresh rhizomes in 'Alpinia galanga is coarsely ground, taking care not to cause excessive heating of the ground parts.
  • the water content of the ground product thus obtained is determined and it is macerated in 7 liters of ethanol, the title of which is chosen so that, taking into account the water content of the ground material, the maceration solvent is 50% ethanol.
  • the ground material is extracted at reflux with the maceration solvent for 30 minutes. This solvent is removed and replaced with an equal weight of 50% ethanol, and the ground material is again extracted at reflux for 30 minutes. The operation is repeated once.
  • the 3 extracts obtained are combined (thus constituting a volume of about 19 liters), filtered on paper, then evaporated to dryness under reduced pressure.
  • a residue is obtained which weighs approximately 50 g, ie an approximate yield of 30% relative to the dry weight of the rhizomes.
  • This extract contains the various shogaols present in the rhizomes of Alpinia galanga ([3] -shogaol, [6] -shogaol and [8] -shogaol) and its [3] -shogaol content is generally between 1 and 5% (w / w) depending on the rhizomes used.
  • [3] -shogaol can be obtained from rhizomes of 'Alpinia galanga by preparing a crude extract of these rhizomes in accordance with Example 1, then purifying this extract in accordance with Example 2 and then subjecting the extract thus purified by successive elutions on columns of silica gel, for example in the following manner.
  • This powder is deposited at the top of a column 10 cm in diameter and 50 cm in height, also containing G60 silica gel in petroleum ether. First eluted with petroleum ether until the residue is less than 0.1% (approximately 10 liters of petroleum ether necessary to reach this stage), then with 12 liters of benzene and , finally, per 8 liters of chloroform.
  • the chloroform phase is evaporated to dryness under reduced pressure, leaving room for a residue of approximately 2.3 g.
  • This residue is then subjected to preparative chromatography on a column 5 cm in diameter and 20 cm in height, filled with Cl 8 silica gel, and using a water / acetonitrile mixture (70/30) as an elution gradient. .
  • the fraction containing [3] -shogaol is eluted in a time between 5 and 7 minutes for a flow rate of 30 ml / min.
  • [3] -shogaol can be identified by high pressure liquid chromatography (HPLC) coupled with mass spectrometry.
  • HPLC high pressure liquid chromatography
  • capsules can be made from [3] -shogaol to obtain a unit dosage of 25 mg of [3] -shogaol.
  • Example 5 Shogaol test on mice: functional study and sexual behavior.
  • mice weigh 30 g for males and 25 g for females. They are conditioned by 8 males per 545 cm2 cage and 5 females + 1 male per cage.
  • the shogaol is suspended in water at the rate of 0.09 mg of active ingredient / 200 ml of solution.
  • the mice receive by gavage 3 mg / kg of active ingredient per day.
  • the males in the SH + group seem less aggressive than the males in the control group: no aggression between congeners.
  • the males in the SH + group show more developed sexual activity than the males in the control group.
  • the male is brought into contact with the females, there is a change in the behavior of the SH + male: round back, ruffled hair, pursuit of the females, uncontrolled ejaculation.
  • This sexual activity continues in the presence of full females.
  • the percentage of females taken by the male is identical (68%), the results show that the females are taken more quickly in the SH + group than in the control group.
  • the following table shows the percentage of whelping females by date:
  • mice of the SH + batch are one day ahead of the control batch and therefore that coitus was more spicy with the SH + males.
  • 32% of the females are new full versus 11% for the females in the control batch.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP02713011A 2001-03-05 2002-03-05 Utilisation d'un ou plusieurs shogaol(s) en tant qu'aphrodisiaque Withdrawn EP1368012A2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0102961 2001-03-05
FR0102961A FR2821553B1 (fr) 2001-03-05 2001-03-05 Utilisation d'un ou plusieurs shogaol (s) en tant qu'aphrodisiaque
PCT/FR2002/000784 WO2002070069A2 (fr) 2001-03-05 2002-03-05 Utilisation d'un ou plusieurs shogaol(s) en tant qu'aphrodisiaque

Publications (1)

Publication Number Publication Date
EP1368012A2 true EP1368012A2 (fr) 2003-12-10

Family

ID=8860733

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02713011A Withdrawn EP1368012A2 (fr) 2001-03-05 2002-03-05 Utilisation d'un ou plusieurs shogaol(s) en tant qu'aphrodisiaque

Country Status (11)

Country Link
US (1) US20050238737A1 (cs)
EP (1) EP1368012A2 (cs)
JP (1) JP2004522790A (cs)
CA (1) CA2442260A1 (cs)
CZ (1) CZ20032634A3 (cs)
FR (1) FR2821553B1 (cs)
HU (1) HUP0303468A2 (cs)
MX (1) MXPA03008052A (cs)
PL (1) PL374103A1 (cs)
SK (1) SK11142003A3 (cs)
WO (1) WO2002070069A2 (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861298B1 (fr) * 2003-10-24 2006-02-17 Lmd Acetoxyacetate de chavicol et ses derives en tant qu'aphrodisiaque
WO2014195479A1 (en) * 2013-06-07 2014-12-11 Nerthus Aps Dry preparation of alpinia galanga or alpinia conchigera with high content of 1's-1'-acetoxychavicol acetate
US10772925B2 (en) 2013-06-07 2020-09-15 Nerthus Aps Composition for enhancing semen quality in a male subject
EP2952201B1 (en) * 2014-06-06 2017-06-21 Nerthus ApS Compositions of Alpinia galanga or Alpinia conchigera with high content of 1'S-1'-acetoxychavicol acetate suitable for pharmaceutical use
JP7176813B2 (ja) * 2017-09-21 2022-11-22 ハウスウェルネスフーズ株式会社 疲労改善用組成物
CN113355166A (zh) * 2021-06-30 2021-09-07 中国热带农业科学院热带作物品种资源研究所 一种抑制单增李斯特菌的高良姜精油的提取方法及高良姜精油

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879682A (en) * 1995-11-24 1999-03-09 Peya Biotech Inc Aframonum seeds for improving penile activity
FR2758086B1 (fr) * 1997-01-09 1999-02-26 Daniel Jean Shogaols pour l'utilisation comme medicaments, produits cosmetiques et produits dietetiques, procede d'obtention desdits shogaols et extraits vegetaux les contenant
JP2001507712A (ja) * 1997-01-09 2001-06-12 ソシエテ デチュード エ ドュ ルシェルシュ アン ファルマコニョジ−エスアエルペ 脱臭組成物の製造におけるショーガオール類およびギンゲロール類の使用
AU1657899A (en) * 1998-12-11 2000-07-03 Peya Biotech Inc. (aframomum) seeds for improving penile activity

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO02070069A2 *

Also Published As

Publication number Publication date
US20050238737A1 (en) 2005-10-27
MXPA03008052A (es) 2004-10-15
CZ20032634A3 (cs) 2004-06-16
SK11142003A3 (sk) 2004-09-08
PL374103A1 (en) 2005-09-19
CA2442260A1 (fr) 2002-09-12
WO2002070069A3 (fr) 2003-01-03
JP2004522790A (ja) 2004-07-29
HUP0303468A2 (hu) 2004-01-28
FR2821553B1 (fr) 2004-07-23
WO2002070069A2 (fr) 2002-09-12
FR2821553A1 (fr) 2002-09-06

Similar Documents

Publication Publication Date Title
JP2005532398A (ja) オリーブ植物水由来のヒドロキシチロソール富化組成物およびその使用方法
FR2698791A1 (fr) Nouveaux extraits de cucurbita sp., procédé pour leur préparation et médicaments et cosmétiques les contenant.
FR2917408A1 (fr) Cyclohexenones d'antrodia camphorata pour le traitement de maladies auto-immunes et compositions pharmaceutiques les contenant
EP1014927B1 (fr) Utilisation des shogaols et des gingerols pour la preparation de compositions deodorantes
FR2581310A1 (fr) Composition therapeutique comportant de l'acide a-linolenique et un compose susceptible de favoriser le passage de l'acide au travers de la membrane cellulaire et extrait de plantes comprenant l'acide et le compose
EP1368012A2 (fr) Utilisation d'un ou plusieurs shogaol(s) en tant qu'aphrodisiaque
EP0068055B1 (fr) Procédé d'obtention d'un extrait stable et désodorisé de sabal serrulatum antiprostatique
JP4693964B2 (ja) 新規摂食抑制剤
RU2240304C2 (ru) Производные гиперфорина, их использование и препараты, содержащие эти производные
EP0317453B1 (fr) Compositions médicamenteuses à base de flavonoides et de saponines extraits de chrysanthellum, leur procédé de préparation et applications thérapeutiques
EP4230214A1 (en) Composition for preventing and treating anti-inflammatory and autoimmune diseases and non-alcoholic fatty liver disease, comprising extract derived from centipeda minima
WO2003080036A2 (fr) Utilisation d'un vanilloide comme anti-ronflement
EP3600370B1 (fr) Utilisation de l'oleoresine de copaifera dans les pathologies de la prostate
EP3607959A1 (en) Formulations containing lipophilic extracts of spicy edible plants useful in controlling pain and inflammation
WO1994002160A1 (en) Tonic
EP1684740A1 (fr) Derives phenylpropanoiques et compositions les contenant stimulant de la libido et de ses mecanismes physiologiques associes
WO2006089881A1 (fr) Utilisation de derives de phenanthrenes en tant qu'agents anti-inflammatoires, procede de synthese et produits intermediaires
WO2001039785A1 (fr) Formulation contenant un extrait de feuille de cacahouete et son procede de preparation
WO2001076551A1 (fr) Composition cosmetique ou pharmaceutique contenant une lactone sesquiterpenique
KR20080100723A (ko) 차전초 정유를 함유하는 콜레스테롤 저하용 조성물
FR2758086A1 (fr) Shogaols pour l'utilisation comme medicaments, produits cosmetiques et produits dietetiques, procede d'obtention desdits shogaols et extraits vegetaux les contenant
JPWO1994002160A1 (ja) 強壮薬
JP2002105017A (ja) 新規肝障害抑制剤
BE1026269A1 (fr) Formulation à propriétés anti-inflammatoires
BE572218A (cs)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030929

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

17Q First examination report despatched

Effective date: 20050504

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050915